A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01782313

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:35.313923+00:00

Published At

2018-08-21T00:00:00+00:00

Record Updated At

2019-09-09

Results Posted At

2018-08-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Recurrent Adult Soft Tissue Sarcoma", "Stage III Adult Soft Tissue Sarcoma", "Stage IV Adult Soft Tissue Sarcoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2019-09-09"

protocolSection.identificationModule.nctId

"NCT01782313"

protocolSection.identificationModule.officialTitle

"A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-08-21"

Study condition terms

• Recurrent Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.